Is Australia still legally bound by the Single Convention on Narcotic Drugs?

Yes. Australia ratified the 1961 Single Convention in 1967 and also acceded to the 1972 amending Protocol. As a signatory, Australia is obligated to limit the production, trade, and use of scheduled substances to medical and scientific purposes, and to maintain domestic legal controls consistent with the treaty. The TGA's Poisons Standard scheduling framework operates within these international obligations.

Did the 2020 UN vote reclassifying cannabis change Australian law?

Not automatically. The December 2020 CND decision removed cannabis from Schedule IV of the 1961 Convention (the most restrictive category), but cannabis remained in Schedule I. Australian domestic law — including the Poisons Standard — is not directly altered by UN CND votes; any changes require a separate domestic regulatory process through the TGA. The international reclassification does, however, affect the policy environment in which domestic reform debates occur.

Who decides which substances go into the UN treaty schedules?

The World Health Organization's Expert Committee on Drug Dependence (ECDD) reviews the scientific and medical evidence and makes scheduling recommendations to the UN Commission on Narcotic Drugs (CND). The CND — made up of member state governments — then votes on whether to accept those recommendations. This means scheduling outcomes reflect both scientific review and geopolitical considerations.

Why was cannabis placed in the most restrictive schedule in 1961?

The placement of cannabis in both Schedule I and Schedule IV of the 1961 Convention reflected the knowledge and political context of the time. The endocannabinoid system had not yet been identified, and the pharmacology of cannabinoids was poorly understood. The scheduling decision was influenced by prevailing assumptions about cannabis addiction potential and by the priorities of the governments negotiating the treaty, rather than by a detailed pharmacological assessment of the kind now required by the WHO ECDD process.

How does the Single Convention relate to Australian scheduling categories like Schedule 8?

The Single Convention established the principle that narcotic drugs should be available only for medical and scientific purposes, with strict controls on supply and prescription. Australia's domestic implementation of this principle is reflected in the Poisons Standard, where high-THC cannabis preparations are classified as Schedule 8 (Controlled Drug). This means they can only be legally supplied under tight prescribing conditions, consistent with the treaty's medical-use framework. Lower-risk preparations may fall under Schedule 4 (Prescription Only), also consistent with the treaty's tiered approach.

The Single Convention on Narcotic Drugs (1961)

By Hannah Bui · 3 June 2026 · 7 min read

Sixty-odd years of one treaty doing a lot of heavy lifting

Seventy-three nations signed a document in New York on 30 March 1961, and it's been quietly running the show ever since. The Single Convention on Narcotic Drugs , formally adopted under the United Nations framework , consolidated nine prior international drug-control treaties into one instrument. On paper, a tidy piece of administrative housekeeping. In practice, it hardwired a particular view of "dangerous substances" into the domestic law of most countries on earth, including Australia.

I'll be honest: I came to this topic sideways. I was pulling apart the regulatory history behind Australia's scheduling framework for a different piece, and kept bumping into 1961 as a kind of invisible wall. Every time I thought I'd found the origin of a classification, the thread led back here. So I went and read the actual treaty. All 51 articles of it. (My cattle dog thought this was a waste of a Tuesday evening. He's probably right.)

What I found was less a neutral scientific document and more a reflection of the geopolitical anxieties of its moment , and that context matters enormously if you want to understand why cannabis, coca, and opium derivatives ended up where they did, and why reclassifying them is such a slow, contested process.

What the Single Convention actually did

Before 1961, international drug control operated through a patchwork of agreements stretching back to the 1912 Hague Convention. The Single Convention replaced all of them. Its stated purpose was to limit the production, manufacture, trade, and use of narcotic drugs to medical and scientific purposes, and to combat drug trafficking through international cooperation.

The treaty established four schedules for controlled substances. Schedule I contained substances deemed to have serious addiction potential; Schedule IV; the most restrictive, was reserved for substances considered especially dangerous with limited or no therapeutic value. Cannabis, cannabis resin, and cannabis extracts were placed in both Schedule I and Schedule IV. That dual-scheduling decision was, to put it plainly, not based on a careful reading of the pharmacology. The science of cannabinoid receptors didn't exist yet; the endocannabinoid system wouldn't be characterised until the late 1980s and early 1990s. The 1961 placement of cannabis was driven largely by the assumptions and political priorities of that era.

The opium poppy, coca leaf, and their derivatives were also listed under Schedule I, though most opiates retained recognised medical use and were not dually listed in Schedule IV. That asymmetry tells you something.

The science that was (and wasn't) at the table

The treaty created a body called the Commission on Narcotic Drugs (CND), sitting under the UN Economic and Social Council, and gave the World Health Organization's Expert Committee on Drug Dependence (ECDD) the role of making scheduling recommendations. Governments could then vote on whether to accept those recommendations.

Here's where I want to be careful with the framing, because this is exactly the kind of detail that gets lost. The WHO's recommendation goes to the CND. The CND can accept or reject it. This means the treaty's scheduling decisions have always been as much a political process as a scientific one. The ECDD reviews the evidence; the member states do the voting.

Cannabis sat in that Schedule I / Schedule IV combination from 1961 until December 2020, when the CND voted, narrowly, 27 votes to 25; to remove it from Schedule IV, following a WHO ECDD recommendation made in 2019. It stayed in Schedule I. So the substance remains internationally controlled, just no longer classified as having "no therapeutic value" at the UN level. A 59-year correction, passed by a margin of two votes. That's the pace of change when science has to move through a political mechanism built in 1961.

For a sense of what that scheduling meant in practice: tetrahydrocannabinol (THC), the principal psychoactive compound in cannabis, was also separately listed under a 1971 Convention on Psychotropic Substances, another layer of international control that intersects with the 1961 framework.

How this flows into Australian law

Australia ratified the Single Convention in 1967. The treaty doesn't automatically become domestic law upon ratification, Australian law requires implementing legislation, but the convention's scheduling logic heavily shaped how substances were categorised in what is now the Poisons Standard (formally the Standard for the Uniform Scheduling of Medicines and Poisons), administered by the Therapeutic Goods Administration.

Under the current Poisons Standard, cannabis preparations containing more than 2% of other cannabinoids (with some exceptions for cannabidiol products) are classified as Schedule 8 controlled drugs; meaning they require a prescription under tight controls, consistent with the convention's "medical use only" approach. You can read more about what that classification means in practice at our Schedule 8 (Controlled Drug) explainer.

The pathway for Australians to legally access cannabis-based medicines runs through the TGA's Special Access Scheme or via an Authorised Prescriber arrangement, structures that exist, in part, because the Single Convention required signatory nations to establish systems limiting access to medical and scientific purposes. You can read more about those access mechanisms in our Special Access Scheme overview.

Psilocybin and MDMA, listed under the 1971 Convention rather than 1961, follow a different but parallel logic, and Australia's rescheduling of psilocybin to Schedule 8 (for use by Authorised Prescribers only, from February 2023) was not inconsistent with Australia's treaty obligations, because the 1971 Convention also permits medical use. The international framework permits more flexibility than most people realise; the bottleneck has often been domestic political will, not treaty obligation. I'd argue that distinction is consistently underreported in public debate about drug law reform, and it matters.

The 1972 Protocol and what followed

The original 1961 treaty was amended by a 1972 Protocol, which strengthened provisions around treatment and rehabilitation of drug-dependent persons and gave the International Narcotics Control Board (INCB) enhanced powers to monitor compliance. Australia acceded to the Protocol as well.

The INCB; established by the Single Convention itself, is the independent, quasi-judicial body that monitors implementation of the international drug control treaties. It publishes annual reports, and its correspondence with member governments about compliance (including on cannabis legalisation moves in Uruguay, Canada, and various US states) gives you a useful window into the ongoing tension between treaty commitments and domestic policy experimentation.

The 1961 Convention also interacts with the 1988 UN Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, which Australia also ratified. That third treaty tightened criminal law obligations around trafficking. Together, these three instruments form the backbone of the international drug control regime that all Australian scheduling and enforcement frameworks sit within.

Reading the treaty with modern eyes

I think it's worth being precise about what the Single Convention was and wasn't. It wasn't a scientific consensus document. It was a diplomatic instrument negotiated by governments with varying priorities: some wanted unified control over opium-producing regions, some were responding to post-war anxieties about addiction, some were representing producer nations with commercial interests in coca or opium. The science available in 1961 was real but limited, and the scheduling decisions reflected the knowledge gaps of the time as much as the evidence that existed.

None of that makes the treaty irrelevant. It's still in force, still ratified by Australia, and still the international reference point against which domestic law is benchmarked. But understanding its origins helps explain why reclassification is difficult, why "scheduling" is not a pure scientific determination, and why, when you see a substance listed under the Poisons Standard; it's worth tracing the full lineage of that classification back through the CND, the ECDD, and in some cases all the way to a vote taken in New York more than six decades ago.

For anyone trying to understand where modern Australian frameworks around cannabinoids sit, the 1961 Convention is genuinely the starting point. The Schedule 4 (Prescription Only) classification that applies to lower-risk cannabis preparations, and the Schedule 8 controls on higher-THC products, both trace their philosophical lineage here, even if Australian regulators have adapted and updated the framework substantially since 1967.

Sources

, Hannah Bui, Evidence & research-literacy writer

Common questions

Is Australia still legally bound by the Single Convention on Narcotic Drugs?: Yes. Australia ratified the 1961 Single Convention in 1967 and also acceded to the 1972 amending Protocol. As a signatory, Australia is obligated to limit the production, trade, and use of scheduled substances to medical and scientific purposes, and to maintain domestic legal controls consistent with the treaty. The TGA's Poisons Standard scheduling framework operates within these international obligations.
Did the 2020 UN vote reclassifying cannabis change Australian law?: Not automatically. The December 2020 CND decision removed cannabis from Schedule IV of the 1961 Convention (the most restrictive category), but cannabis remained in Schedule I. Australian domestic law — including the Poisons Standard — is not directly altered by UN CND votes; any changes require a separate domestic regulatory process through the TGA. The international reclassification does, however, affect the policy environment in which domestic reform debates occur.
Who decides which substances go into the UN treaty schedules?: The World Health Organization's Expert Committee on Drug Dependence (ECDD) reviews the scientific and medical evidence and makes scheduling recommendations to the UN Commission on Narcotic Drugs (CND). The CND — made up of member state governments — then votes on whether to accept those recommendations. This means scheduling outcomes reflect both scientific review and geopolitical considerations.
Why was cannabis placed in the most restrictive schedule in 1961?: The placement of cannabis in both Schedule I and Schedule IV of the 1961 Convention reflected the knowledge and political context of the time. The endocannabinoid system had not yet been identified, and the pharmacology of cannabinoids was poorly understood. The scheduling decision was influenced by prevailing assumptions about cannabis addiction potential and by the priorities of the governments negotiating the treaty, rather than by a detailed pharmacological assessment of the kind now required by the WHO ECDD process.
How does the Single Convention relate to Australian scheduling categories like Schedule 8?: The Single Convention established the principle that narcotic drugs should be available only for medical and scientific purposes, with strict controls on supply and prescription. Australia's domestic implementation of this principle is reflected in the Poisons Standard, where high-THC cannabis preparations are classified as Schedule 8 (Controlled Drug). This means they can only be legally supplied under tight prescribing conditions, consistent with the treaty's medical-use framework. Lower-risk preparations may fall under Schedule 4 (Prescription Only), also consistent with the treaty's tiered approach.